3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Burkitt Lymphoma
20
Leukemia, Biphenotypic, Acute
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia
4
Recurrence
3
Neoplasm, Residual
2
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Large Granular Lymphocytic
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Down Syndrome
1
Blast Crisis
1
Bites and Stings
1
Interventions
pembrolizumab
38
Bevacizumab
25
Cyclophosphamide
22
Blood Specimen Collection
19
Standard of Care
18
Carboplatin
17
Nivolumab
16
Paclitaxel
15
Exercise
15
Gemcitabine
14
atezolizumab
12
Radiotherapy
12
Pemetrexed
12
Cisplatin
12
Fluorouracil
11
Doxorubicin
11
Cetuximab
10
Rituximab
9
Oxaliplatin
9
Magnetic Resonance Spectroscopy
9
Leucovorin
9
Biopsy
9
130-nm albumin-bound paclitaxel
9
durvalumab
8
abemaciclib
8
Temozolomide
8
Surveys and Questionnaires
8
Prednisone
8
Docetaxel
8
olaparib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms
×
blinatumomab
×
90 days
×
Clear all
No trials found.